María Tereza Nieto-CoronelNancy Reynoso‐NoverónClaudia Arce-SalinasCristian Salinas2026-03-222026-03-22202510.1016/j.suronc.2025.102304https://doi.org/10.1016/j.suronc.2025.102304https://andeanlibrary.org/handle/123456789/78045enMedicineOverall survivalInternal medicineOncologyRetrospective cohort studySurvival analysisProspective cohort studySurvival rateOverall survival improvement with locoregional control in patients with metastatic breast cancer. Single-institution experiencearticle